CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

40.64  +0.02 (+0.05%)

Fundamental Rating

4

Overall CCJ gets a fundamental rating of 4 out of 10. We evaluated CCJ against 217 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ has a great financial health rating, but its profitability evaluates not so good. CCJ is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

CCJ had positive earnings in the past year.
In the past year CCJ had a positive cash flow from operations.
In multiple years CCJ reported negative net income over the last 5 years.
Each year in the past 5 years CCJ had a positive operating cash flow.

1.2 Ratios

CCJ has a Return On Assets of 1.13%. This is in the lower half of the industry: CCJ underperforms 78.34% of its industry peers.
Looking at the Return On Equity, with a value of 1.64%, CCJ is doing worse than 77.42% of the companies in the same industry.
CCJ has a Return On Invested Capital of 0.57%. This is amonst the worse of the industry: CCJ underperforms 81.11% of its industry peers.
Industry RankSector Rank
ROA 1.13%
ROE 1.64%
ROIC 0.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 4.69%, CCJ is doing worse than 74.19% of the companies in the same industry.
In the last couple of years the Profit Margin of CCJ has grown nicely.
The Operating Margin of CCJ (2.65%) is worse than 79.72% of its industry peers.
In the last couple of years the Operating Margin of CCJ has declined.
CCJ's Gross Margin of 17.67% is on the low side compared to the rest of the industry. CCJ is outperformed by 73.73% of its industry peers.
In the last couple of years the Gross Margin of CCJ has declined.
Industry RankSector Rank
OM 2.65%
PM 4.69%
GM 17.67%
OM growth 3Y-45.2%
OM growth 5Y-40.33%
PM growth 3Y6.4%
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-9.19%

7

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CCJ has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCJ has more shares outstanding
The debt/assets ratio for CCJ has been reduced compared to a year ago.

2.2 Solvency

CCJ has an Altman-Z score of 6.38. This indicates that CCJ is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CCJ (6.38) is better than 90.32% of its industry peers.
CCJ has a debt to FCF ratio of 5.29. This is a neutral value as CCJ would need 5.29 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.29, CCJ is in line with its industry, outperforming 47.00% of the companies in the same industry.
CCJ has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
CCJ has a Debt to Equity ratio of 0.08. This is in the better half of the industry: CCJ outperforms 79.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 5.29
Altman-Z 6.38
ROIC/WACC0.1
WACC8.08%

2.3 Liquidity

CCJ has a Current Ratio of 3.64. This indicates that CCJ is financially healthy and has no problem in meeting its short term obligations.
CCJ has a better Current ratio (3.64) than 86.64% of its industry peers.
CCJ has a Quick Ratio of 3.00. This indicates that CCJ is financially healthy and has no problem in meeting its short term obligations.
CCJ's Quick ratio of 3.00 is amongst the best of the industry. CCJ outperforms 83.41% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 171.43% over the past year.
Measured over the past years, CCJ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
Looking at the last year, CCJ shows a quite strong growth in Revenue. The Revenue has grown by 16.84% in the last year.
CCJ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.84% yearly.
EPS 1Y171.43%
EPS 3Y45.67%
EPS 5Y17.78%
EPS growth Q2Q-105.56%
Revenue growth 1Y16.84%
Revenue growth 3Y0.09%
Revenue growth 5Y-2.84%
Revenue growth Q2Q-13.56%

3.2 Future

CCJ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.85% yearly.
Based on estimates for the next years, CCJ will show a small growth in Revenue. The Revenue will grow by 6.72% on average per year.
EPS Next Y123.72%
EPS Next 2Y114.84%
EPS Next 3Y78.05%
EPS Next 5Y37.85%
Revenue Next Year42.36%
Revenue Next 2Y17.97%
Revenue Next 3Y14.2%
Revenue Next 5Y6.72%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 145.14, the valuation of CCJ can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CCJ indicates a slightly more expensive valuation: CCJ is more expensive than 79.72% of the companies listed in the same industry.
CCJ is valuated expensively when we compare the Price/Earnings ratio to 25.55, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 34.96, the valuation of CCJ can be described as expensive.
72.35% of the companies in the same industry are cheaper than CCJ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 18.74, CCJ is valued quite expensively.
Industry RankSector Rank
PE 145.14
Fwd PE 34.96

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCJ indicates a slightly more expensive valuation: CCJ is more expensive than 78.80% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCJ indicates a slightly more expensive valuation: CCJ is more expensive than 70.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 126.02
EV/EBITDA 89.45

4.3 Compensation for Growth

CCJ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CCJ's earnings are expected to grow with 78.05% in the coming years.
PEG (NY)1.17
PEG (5Y)8.16
EPS Next 2Y114.84%
EPS Next 3Y78.05%

3

5. Dividend

5.1 Amount

CCJ has a yearly dividend return of 0.23%, which is pretty low.
CCJ's Dividend Yield is slightly below the industry average, which is at 6.69.
Compared to an average S&P500 Dividend Yield of 2.64, CCJ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.23%

5.2 History

The dividend of CCJ decreases each year by -20.75%.
CCJ has been paying a dividend for at least 10 years, so it has a reliable track record.
CCJ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-20.75%
Div Incr Years1
Div Non Decr Years4

5.3 Sustainability

53.11% of the earnings are spent on dividend by CCJ. This is a bit on the high side, but may be sustainable.
DP53.11%
EPS Next 2Y114.84%
EPS Next 3Y78.05%

CAMECO CORP

NYSE:CCJ (9/27/2023, 2:21:09 PM)

40.64

+0.02 (+0.05%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-02 2023-08-02/bmo
Earnings (Next)10-25 2023-10-25/bmo
Inst Owners68.73%
Inst Owner Change-29.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.61B
Analysts85.71
Price Target37.84 (-6.89%)
Dividend
Industry RankSector Rank
Dividend Yield 0.23%
Dividend Growth(5Y)-20.75%
DP53.11%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-50.89%
Min EPS beat(2)-107.86%
Max EPS beat(2)6.08%
EPS beat(4)2
Avg EPS beat(4)-14.22%
Min EPS beat(4)-107.86%
Max EPS beat(4)59.12%
Revenue beat(2)2
Avg Revenue beat(2)99164.3%
Min Revenue beat(2)97094%
Max Revenue beat(2)101235%
Revenue beat(4)4
Avg Revenue beat(4)102709%
Min Revenue beat(4)96409.1%
Max Revenue beat(4)116098%
PT rev (1m)-0.65%
PT rev (3m)3.47%
EPS NQ rev (1m)-7.14%
EPS NQ rev (3m)-25.29%
EPS NY rev (1m)-11.03%
EPS NY rev (3m)-27.07%
Revenue NQ rev (1m)-99.86%
Revenue NQ rev (3m)-99.86%
Revenue NY rev (1m)0.88%
Revenue NY rev (3m)7.81%
Valuation
Industry RankSector Rank
PE 145.14
Fwd PE 34.96
P/S 11.42
P/FCF 126.02
P/OCF 71.41
P/B 3.98
P/tB 4.01
EV/EBITDA 89.45
EPS(TTM)0.28
EY0.69%
EPS(NY)1.16
Fwd EY2.86%
FCF(TTM)0.32
FCFY0.79%
OCF(TTM)0.57
OCFY1.4%
SpS3.56
BVpS10.21
TBVpS10.13
PEG (NY)1.17
PEG (5Y)8.16
Profitability
Industry RankSector Rank
ROA 1.13%
ROE 1.64%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.84%
ROICexgc 0.84%
OM 2.65%
PM 4.69%
GM 17.67%
FCFM 9.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-44.26%
ROICexcg growth 5Y-40.2%
ROICexc growth 3Y-44.22%
ROICexc growth 5Y-40.17%
OM growth 3Y-45.2%
OM growth 5Y-40.33%
PM growth 3Y6.4%
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-9.19%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 5.29
Debt/EBITDA 2
Cap/Depr 74.44%
Cap/Sales 6.93%
Profit Quality 193.07%
Current Ratio 3.64
Quick Ratio 3
Altman-Z 6.38
F-Score6
WACC8.08%
ROIC/WACC0.1
Cap/Depr(3y)56.63%
Cap/Depr(5y)42.81%
Cap/Sales(3y)6.23%
Cap/Sales(5y)5.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y171.43%
EPS 3Y45.67%
EPS 5Y17.78%
EPS growth Q2Q-105.56%
EPS Next Y123.72%
EPS Next 2Y114.84%
EPS Next 3Y78.05%
EPS Next 5Y37.85%
Revenue growth 1Y16.84%
Revenue growth 3Y0.09%
Revenue growth 5Y-2.84%
Revenue growth Q2Q-13.56%
Revenue Next Year42.36%
Revenue Next 2Y17.97%
Revenue Next 3Y14.2%
Revenue Next 5Y6.72%
EBIT growth 1Y90.29%
EBIT growth 3Y-45.15%
EBIT growth 5Y-42.02%
EBIT Next Year479.15%
EBIT Next 3Y134.08%
EBIT Next 5Y63.99%
FCF growth 1Y-39.72%
FCF growth 3Y-29.08%
FCF growth 5Y-19.68%
OCF growth 1Y-14.14%
OCF growth 3Y-16.7%
OCF growth 5Y-12.57%